{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:19:34Z","timestamp":1792513174334,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,4,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Signal transducer and activator of transcription 3 (STAT3) has been shown to upregulate gene transcription during tumorigenesis. However, how STAT3 initiates transcription remains to be exploited. This study is to reveal the role of CREPT (cell cycle-related and elevated-expression protein in tumours, or RPRD1B) in promoting STAT3 transcriptional activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>BALB\/c nude mice, CREPT overexpression or deletion cells were employed for the assay of tumour formation, chromatin immunoprecipitation, assay for transposase-accessible chromatin using sequencing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We demonstrate that CREPT, a recently identified oncoprotein, enhances STAT3 transcriptional activity to promote tumorigenesis. CREPT expression is positively correlated with activation of STAT3 signalling in tumours. Deletion of CREPT led to a decrease, but overexpression of CREPT resulted in an increase, in STAT3-initiated tumour cell proliferation, colony formation and tumour growth. Mechanistically, CREPT interacts with phosphorylated STAT3 (p-STAT3) and facilitates p-STAT3 to recruit p300 to occupy at the promoters of STAT3-targeted genes. Therefore, CREPT and STAT3 coordinately facilitate p300-mediated acetylation of histone 3 (H3K18ac and H3K27ac), further augmenting RNA polymerase II recruitment. Accordingly, depletion of p300 abolished CREPT-enhanced STAT3 transcriptional activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We propose that CREPT is a co-activator of STAT3 for recruiting p300. Our study provides an alternative strategy for the therapy of cancers related to STAT3.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-021-01269-1","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:17:07Z","timestamp":1612311427000},"page":"1437-1448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["CREPT\/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner"],"prefix":"10.1038","volume":"124","author":[{"given":"Wanli","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9012-2869","authenticated-orcid":false,"given":"Xiongjun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshen","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Eugene Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoqing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3356-506X","authenticated-orcid":false,"given":"Bingtao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangli","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1567-3227","authenticated-orcid":false,"given":"Zhijie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"1269_CR1","doi-asserted-by":"crossref","first-page":"e28086","DOI":"10.4161\/jkst.28086","volume":"3","author":"Y Teng","year":"2014","unstructured":"Teng, Y., Ross, J. L. & Cowell, J. K. The involvement of JAK-STAT3 in cell motility, invasion, and metastasis. JAK-STAT 3, e28086 (2014).","journal-title":"JAK-STAT"},{"key":"1269_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.onc.1206122","volume":"22","author":"D Wei","year":"2003","unstructured":"Wei, D., Le, X., Zheng, L., Wang, L., Frey, J. A., Gao, A. C. et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22, 319\u2013329 (2003).","journal-title":"Oncogene"},{"key":"1269_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02258360","volume":"5","author":"R Garcia","year":"1998","unstructured":"Garcia, R. & Jove, R. Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J. Biomed. Sci. 5, 79\u201385 (1998).","journal-title":"J. Biomed. Sci."},{"key":"1269_CR4","doi-asserted-by":"crossref","first-page":"ra9","DOI":"10.1126\/scisignal.2001426","volume":"4","author":"R Ahmad","year":"2011","unstructured":"Ahmad, R., Rajabi, H., Kosugi, M., Joshi, M. D., Alam, M., Vasir, B. et al. MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop. Sci. Signal. 4, ra9 (2011).","journal-title":"Sci. Signal."},{"key":"1269_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.7541555","volume":"269","author":"CL Yu","year":"1995","unstructured":"Yu, C. L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J. et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81\u201383 (1995).","journal-title":"Science"},{"key":"1269_CR6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell Jr.","year":"1997","unstructured":"Darnell, J. E. Jr. STATs and gene regulation. Science 277, 1630\u20131635 (1997).","journal-title":"Science"},{"key":"1269_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H. & Schreiber, R. D. How cells respond to interferons. Annu. Rev. Biochem. 67, 227\u2013264 (1998).","journal-title":"Annu. Rev. Biochem."},{"key":"1269_CR8","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/MCB.18.5.2545","volume":"18","author":"J Turkson","year":"1998","unstructured":"Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P. & Jove, R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18, 2545\u20132552 (1998).","journal-title":"Mol. Cell. Biol."},{"key":"1269_CR9","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1158\/0008-5472.CAN-05-2203","volume":"66","author":"K Leslie","year":"2006","unstructured":"Leslie, K., Lang, C., Devgan, G., Azare, J., Berishaj, M., Gerald, W. et al. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res. 66, 2544\u20132552 (2006).","journal-title":"Cancer Res."},{"key":"1269_CR10","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1073\/pnas.131568898","volume":"98","author":"T Bowman","year":"2001","unstructured":"Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M. et al. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl Acad. Sci. USA 98, 7319\u20137324 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1269_CR11","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1073\/pnas.98.4.1543","volume":"98","author":"Y Shen","year":"2001","unstructured":"Shen, Y., Devgan, G., Darnell, J. E. Jr. & Bromberg, J. F. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl Acad. Sci. USA 98, 1543\u20131548 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1269_CR12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1078-0432.CCR-04-1752","volume":"12","author":"T Gritsko","year":"2006","unstructured":"Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M. et al. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin. Cancer Res. 12, 11\u201319 (2006).","journal-title":"Clin. Cancer Res."},{"key":"1269_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","volume":"7","author":"H Yu","year":"2007","unstructured":"Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7, 41\u201351 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1269_CR14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1084\/jem.20051848","volume":"203","author":"H Sumimoto","year":"2006","unstructured":"Sumimoto, H., Imabayashi, F., Iwata, T. & Kawakami, Y. The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J. Exp. Med. 203, 1651\u20131656 (2006).","journal-title":"J. Exp. Med."},{"key":"1269_CR15","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.4049\/jimmunol.172.7.4630","volume":"172","author":"JP Herbeuval","year":"2004","unstructured":"Herbeuval, J. P., Lelievre, E., Lambert, C., Dy, M. & Genin, C. Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. J. Immunol. 172, 4630\u20134636 (2004).","journal-title":"J. Immunol."},{"key":"1269_CR16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1084\/jem.20052333","volume":"203","author":"I Kinjyo","year":"2006","unstructured":"Kinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K. et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203, 1021\u20131031 (2006).","journal-title":"J. Exp. Med."},{"key":"1269_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","volume":"15","author":"S Grivennikov","year":"2009","unstructured":"Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G. Y., Vallabhapurapu, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103\u2013113 (2009).","journal-title":"Cancer Cell"},{"key":"1269_CR18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2005.07.075","volume":"335","author":"FC Hsieh","year":"2005","unstructured":"Hsieh, F. C., Cheng, G. & Lin, J. Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem. Biophys. Res. Commun. 335, 292\u2013299 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1269_CR19","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1073\/pnas.1121606109","volume":"109","author":"X Zhang","year":"2012","unstructured":"Zhang, X., Yue, P., Page, B. D., Li, T., Zhao, W., Namanja, A. T. et al. Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc. Natl Acad. Sci. USA 109, 9623\u20139628 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1269_CR20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ejmech.2018.08.037","volume":"157","author":"W Huang","year":"2018","unstructured":"Huang, W., Liu, Y., Wang, J., Yuan, X., Jin, H. W., Zhang, L. R. et al. Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis. Eur. J. Med. Chem. 157, 887\u2013897 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"1269_CR21","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/cb500071v","volume":"9","author":"W Huang","year":"2014","unstructured":"Huang, W., Dong, Z., Wang, F., Peng, H., Liu, J. Y. & Zhang, J. T. A small molecule compound targeting STAT3 DNA-binding domain inhibits cancer cell proliferation, migration, and invasion. ACS Chem. Biol. 9, 1188\u20131196 (2014).","journal-title":"ACS Chem. Biol."},{"key":"1269_CR22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu, H., Lee, H., Herrmann, A., Buettner, R. & Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat. Rev. Cancer 14, 736\u2013746 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"1269_CR23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/35073094","volume":"2","author":"GS Martin","year":"2001","unstructured":"Martin, G. S. The hunting of the Src. Nat. Rev. Mol. Cell Biol. 2, 467\u2013475 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1269_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G. & Schaper, F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1\u201320 (2003).","journal-title":"Biochem. J."},{"key":"1269_CR25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/jir.1998.18.549","volume":"18","author":"JE Darnell Jr.","year":"1998","unstructured":"Darnell, J. E. Jr. Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interferon Cytokine Res. 18, 549\u2013554 (1998).","journal-title":"J. Interferon Cytokine Res."},{"key":"1269_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.it.2010.01.005","volume":"31","author":"Z Yagil","year":"2010","unstructured":"Yagil, Z., Nechushtan, H., Kay, G., Yang, C. M., Kemeny, D. M. & Razin, E. The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response. Trends Immunol. 31, 199\u2013204 (2010).","journal-title":"Trends Immunol."},{"key":"1269_CR27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","volume":"7","author":"A Yoshimura","year":"2007","unstructured":"Yoshimura, A., Naka, T. & Kubo, M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454\u2013465 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"1269_CR28","volume":"7","author":"L Ni","year":"2017","unstructured":"Ni, L., Wang, L., Yao, C., Ni, Z., Liu, F., Gong, C. et al. The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3. Sci. Rep. 7, 45266 (2017).","journal-title":"Sci. Rep."},{"key":"1269_CR29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/mend.16.4.0811","volume":"16","author":"S Ray","year":"2002","unstructured":"Ray, S., Sherman, C. T., Lu, M. & Brasier, A. R. Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300\/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity. Mol. Endocrinol. 16, 824\u2013836 (2002).","journal-title":"Mol. Endocrinol."},{"key":"1269_CR30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1105166","volume":"307","author":"ZL Yuan","year":"2005","unstructured":"Yuan, Z. L., Guan, Y. J., Chatterjee, D. & Chin, Y. E. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307, 269\u2013273 (2005).","journal-title":"Science"},{"key":"1269_CR31","doi-asserted-by":"crossref","first-page":"30725","DOI":"10.1074\/jbc.M805941200","volume":"283","author":"T Hou","year":"2008","unstructured":"Hou, T., Ray, S., Lee, C. & Brasier, A. R. The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain. J. Biol. Chem. 283, 30725\u201330734 (2008).","journal-title":"J. Biol. Chem."},{"key":"1269_CR32","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1101\/gad.1135003","volume":"17","author":"L Lerner","year":"2003","unstructured":"Lerner, L., Henriksen, M. A., Zhang, X. & Darnell, J. E. Jr. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 17, 2564\u20132577 (2003).","journal-title":"Genes Dev."},{"key":"1269_CR33","doi-asserted-by":"crossref","first-page":"e22018","DOI":"10.1371\/journal.pone.0022018","volume":"6","author":"PY Cheng","year":"2011","unstructured":"Cheng, P. Y., Lin, Y. P., Chen, Y. L., Lee, Y. C., Tai, C. C., Wang, Y. T. et al. Interplay between SIN3A and STAT3 mediates chromatin conformational changes and GFAP expression during cellular differentiation. PLoS ONE 6, e22018 (2011).","journal-title":"PLoS ONE"},{"key":"1269_CR34","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1074\/jbc.M111486200","volume":"277","author":"S Giraud","year":"2002","unstructured":"Giraud, S., Bienvenu, F., Avril, S., Gascan, H., Heery, D. M. & Coqueret, O. Functional interaction of STAT3 transcription factor with the coactivator NcoA\/SRC1a. J. Biol. Chem. 277, 8004\u20138011 (2002).","journal-title":"J. Biol. Chem."},{"key":"1269_CR35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ccr.2011.12.016","volume":"21","author":"D Lu","year":"2012","unstructured":"Lu, D., Wu, Y., Wang, Y., Ren, F., Wang, D., Su, F. et al. CREPT accelerates tumorigenesis by regulating the transcription of cell-cycle-related genes. Cancer Cell 21, 92\u2013104 (2012).","journal-title":"Cancer Cell"},{"key":"1269_CR36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.molcel.2014.01.020","volume":"53","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Ning, H., Ren, F., Zhang, Y., Rong, Y., Wang, Y. et al. GdX\/UBL4A specifically stabilizes the TC45\/STAT3 association and promotes dephosphorylation of STAT3 to repress tumorigenesis. Mol. Cell 53, 752\u2013765 (2014).","journal-title":"Mol. Cell"},{"key":"1269_CR37","doi-asserted-by":"crossref","first-page":"e0174309","DOI":"10.1371\/journal.pone.0174309","volume":"12","author":"J Ma","year":"2017","unstructured":"Ma, J., Ren, Y., Zhang, L., Kong, X., Wang, T., Shi, Y. et al. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression. PLoS ONE 12, e0174309 (2017).","journal-title":"PLoS ONE"},{"key":"1269_CR38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.bbrc.2016.10.067","volume":"480","author":"G Zheng","year":"2016","unstructured":"Zheng, G., Li, W., Zuo, B., Guo, Z., Xi, W., Wei, M. et al. High expression of CREPT promotes tumor growth and is correlated with poor prognosis in colorectal cancer. Biochem. Biophys. Res. Commun. 480, 436\u2013442 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1269_CR39","volume":"9","author":"L Ding","year":"2018","unstructured":"Ding, L., Yang, L., He, Y., Zhu, B., Ren, F., Fan, X. et al. CREPT\/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2\/M transition in gastric cancer. Cell Death Dis. 9, 1172 (2018).","journal-title":"Cell Death Dis."},{"key":"1269_CR40","first-page":"6596","volume":"7","author":"Y She","year":"2014","unstructured":"She, Y., Liang, J., Chen, L., Qiu, Y., Liu, N., Zhao, X. et al. CREPT expression correlates with poor prognosis in patients with retroperitoneal leiomyosarcoma. Int. J. Clin. Exp. Pathol. 7, 6596\u20136605 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"1269_CR41","doi-asserted-by":"publisher","unstructured":"Liu, H., Seynhaeve, A. L. B., Brouwer, R. W. W., van IJcken, W. F. J., Yang, L., Wang, Y. et al. CREPT promotes melanoma progression through accelerated proliferation and enhanced migration by RhoA-mediated actin filaments and focal adhesion formation. Cancers 12, https:\/\/doi.org\/10.3390\/cancers12010033 (2019).","DOI":"10.3390\/cancers12010033"},{"key":"1269_CR42","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/ijc.32627","volume":"146","author":"MA Komor","year":"2020","unstructured":"Komor, M. A., de Wit, M., van den Berg, J., Martens de Kemp, S. R., Delis-van Diemen, P. M., Bolijn, A. S. et al. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression. Int. J. Cancer 146, 1979\u20131992 (2020).","journal-title":"Int. J. Cancer"},{"key":"1269_CR43","doi-asserted-by":"publisher","unstructured":"Yang, G., Wang, Y., Xiao, J., Zhao, F., Qiu, J., Liu, Y. et al. CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma. Cell. Oncol. https:\/\/doi.org\/10.1007\/s13402-020-00569-7 (2020).","DOI":"10.1007\/s13402-020-00569-7"},{"key":"1269_CR44","doi-asserted-by":"publisher","unstructured":"Li, M. M. D. & Chang, Z. Current understanding of CREPT and p15RS, carboxy-terminal domain (CTD)-interacting proteins, in human cancers. Oncogene https:\/\/doi.org\/10.1038\/s41388-020-01544-0 (in the press).","DOI":"10.1038\/s41388-020-01544-0"},{"key":"1269_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41467-020-20636-9","volume":"12","author":"LYH Yang","year":"2021","unstructured":"Yang, L. Y. H., Chu, Y., Song, Y., Ding, L., Zhu, B. et al. CREPT is required for murine stem cell maintenance during intestinal regeneration. Nat. Commun. 12, 270 https:\/\/doi.org\/10.1038\/s41467-020-20636-9 (2021).","journal-title":"Nat. Commun."},{"key":"1269_CR46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4161\/trns.2.5.17803","volume":"2","author":"Z Ni","year":"2011","unstructured":"Ni, Z., Olsen, J. B., Guo, X., Zhong, G., Ruan, E. D., Marcon, E. et al. Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B. Transcription 2, 237\u2013242 (2011).","journal-title":"Transcription"},{"key":"1269_CR47","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/nar\/gkv1492","volume":"44","author":"PL Patidar","year":"2016","unstructured":"Patidar, P. L., Motea, E. A., Fattah, F. J., Zhou, Y., Morales, J. C., Xie, Y. et al. The Kub5-Hera\/RPRD1B interactome: a novel role in preserving genetic stability by regulating DNA mismatch repair. Nucleic Acids Res. 44, 1718\u20131731 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1269_CR48","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1038\/s41388-018-0161-z","volume":"37","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Wang, S., Kang, W., Liu, C., Dong, Y., Ren, F. et al. CREPT facilitates colorectal cancer growth through inducing Wnt\/beta-catenin pathway by enhancing p300-mediated beta-catenin acetylation. Oncogene 37, 3485\u20133500 (2018).","journal-title":"Oncogene"},{"key":"1269_CR49","doi-asserted-by":"crossref","first-page":"22589","DOI":"10.1074\/jbc.M114.560979","volume":"289","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Liu, C., Duan, X., Ren, F., Li, S., Jin, Z. et al. CREPT\/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the beta-catenin.TCF4 transcriptional activity in response to Wnt signaling. J. Biol. Chem. 289, 22589\u201322599 (2014).","journal-title":"J. Biol. Chem."},{"key":"1269_CR50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/mab.2014.0043","volume":"33","author":"F Ren","year":"2014","unstructured":"Ren, F., Wang, R., Zhang, Y., Liu, C., Wang, Y., Hu, J. et al. Characterization of a monoclonal antibody against CREPT, a novel protein highly expressed in tumors. Monoclon. Antib. Immunodiagn. Immunother. 33, 401\u2013408 (2014).","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"1269_CR51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1089\/jir.1995.15.905","volume":"15","author":"Z Estrov","year":"1995","unstructured":"Estrov, Z., Samal, B., Lapushin, R., Kellokumpu-Lehtinen, P., Sahin, A. A., Kurzrock, R. et al. Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J. Interferon Cytokine Res. 15, 905\u2013913 (1995).","journal-title":"J. Interferon Cytokine Res."},{"key":"1269_CR52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO;2-6","volume":"66","author":"P Kellokumpu-Lehtinen","year":"1996","unstructured":"Kellokumpu-Lehtinen, P., Talpaz, M., Harris, D., Van, Q., Kurzrock, R. & Estrov, Z. Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. Int. J. Cancer 66, 515\u2013519 (1996).","journal-title":"Int. J. Cancer"},{"key":"1269_CR53","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1777","volume":"9","author":"A Quaglino","year":"2007","unstructured":"Quaglino, A., Schere-Levy, C., Romorini, L., Meiss, R. P. & Kordon, E. C. Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling. Breast Cancer Res. 9, R69 (2007).","journal-title":"Breast Cancer Res."},{"key":"1269_CR54","doi-asserted-by":"crossref","first-page":"788","DOI":"10.18632\/oncotarget.1772","volume":"5","author":"X Li","year":"2014","unstructured":"Li, X., Yang, Q., Yu, H., Wu, L., Zhao, Y., Zhang, C. et al. LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway. Oncotarget 5, 788\u2013801 (2014).","journal-title":"Oncotarget"},{"key":"1269_CR55","volume":"5","author":"H Yu","year":"2014","unstructured":"Yu, H., Yue, X., Zhao, Y., Li, X., Wu, L., Zhang, C. et al. LIF negatively regulates tumour-suppressor p53 through Stat3\/ID1\/MDM2 in colorectal cancers. Nat. Commun. 5, 5218 (2014).","journal-title":"Nat. Commun."},{"key":"1269_CR56","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/MCB.16.4.1595","volume":"16","author":"X Cao","year":"1996","unstructured":"Cao, X., Tay, A., Guy, G. R. & Tan, Y. H. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 16, 1595\u20131603 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"1269_CR57","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1158\/0008-5472.CAN-06-1172","volume":"66","author":"Y Rong","year":"2006","unstructured":"Rong, Y., Cheng, L., Ning, H., Zou, J., Zhang, Y., Xu, F. et al. Wilms\u2019 tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms\u2019 tumor. Cancer Res. 66, 8049\u20138057 (2006).","journal-title":"Cancer Res."},{"key":"1269_CR58","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/onc.2009.488","volume":"29","author":"NR West","year":"2010","unstructured":"West, N. R. & Watson, P. H. S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene 29, 2083\u20132092 (2010).","journal-title":"Oncogene"},{"key":"1269_CR59","doi-asserted-by":"crossref","first-page":"38886","DOI":"10.1074\/jbc.M111.286245","volume":"286","author":"M Snyder","year":"2011","unstructured":"Snyder, M., Huang, X. Y. & Zhang, J. J. Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration. J. Biol. Chem. 286, 38886\u201338893 (2011).","journal-title":"J. Biol. Chem."},{"key":"1269_CR60","doi-asserted-by":"crossref","first-page":"e93498","DOI":"10.1371\/journal.pone.0093498","volume":"9","author":"F Beigel","year":"2014","unstructured":"Beigel, F., Friedrich, M., Probst, C., Sotlar, K., Goke, B., Diegelmann, J. et al. Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members. PLoS ONE 9, e93498 (2014).","journal-title":"PLoS ONE"},{"key":"1269_CR61","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1074\/jbc.271.11.5961","volume":"271","author":"A Kaptein","year":"1996","unstructured":"Kaptein, A., Paillard, V. & Saunders, M. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem. 271, 5961\u20135964 (1996).","journal-title":"J. Biol. Chem."},{"key":"1269_CR62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","volume":"82","author":"Z Wen","year":"1995","unstructured":"Wen, Z., Zhong, Z. & Darnell, J. E. Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241\u2013250 (1995).","journal-title":"Cell"},{"key":"1269_CR63","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1126\/science.1217277","volume":"336","author":"B Akhtar-Zaidi","year":"2012","unstructured":"Akhtar-Zaidi, B., Cowper-Sal-lari, R., Corradin, O., Saiakhova, A., Bartels, C. F., Balasubramanian, D. et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 336, 736\u2013739 (2012).","journal-title":"Science"},{"key":"1269_CR64","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1248\/bpb.30.1860","volume":"30","author":"N Ohbayashi","year":"2007","unstructured":"Ohbayashi, N., Ikeda, O., Taira, N., Yamamoto, Y., Muromoto, R., Sekine, Y. et al. LIF- and IL-6-induced acetylation of STAT3 at Lys-685 through PI3K\/Akt activation. Biol. Pharm. Bull. 30, 1860\u20131864 (2007).","journal-title":"Biol. Pharm. Bull."},{"key":"1269_CR65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cell.2013.06.027","volume":"154","author":"Z Tang","year":"2013","unstructured":"Tang, Z., Chen, W. Y., Shimada, M., Nguyen, U. T., Kim, J., Sun, X. J. et al. SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell 154, 297\u2013310 (2013).","journal-title":"Cell"},{"key":"1269_CR66","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.molcel.2019.04.008","volume":"74","author":"I Ali","year":"2019","unstructured":"Ali, I., Ruiz, D. G., Ni, Z., Johnson, J. R., Zhang, H., Li, P. C. et al. Crosstalk between RNA Pol II C-terminal domain acetylation and phosphorylation via RPRD proteins. Mol. Cell 74, 1164\u201374 e4 (2019).","journal-title":"Mol. Cell"},{"key":"1269_CR67","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nsmb.2853","volume":"21","author":"Z Ni","year":"2014","unstructured":"Ni, Z., Xu, C., Guo, X., Hunter, G. O., Kuznetsova, O. V., Tempel, W. et al. RPRD1A and RPRD1B are human RNA polymerase II C-terminal domain scaffolds for Ser5 dephosphorylation. Nat. Struct. Mol. Biol. 21, 686\u2013695 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1269_CR68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11427-013-4589-7","volume":"57","author":"K Mei","year":"2014","unstructured":"Mei, K., Jin, Z., Ren, F., Wang, Y., Chang, Z. & Wang, X. Structural basis for the recognition of RNA polymerase II C-terminal domain by CREPT and p15RS. Sci. China Life Sci. 57, 97\u2013106 (2014).","journal-title":"Sci. China Life Sci."},{"key":"1269_CR69","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.7150\/thno.41677","volume":"10","author":"D Ma","year":"2020","unstructured":"Ma, D., Zou, Y., Chu, Y., Liu, Z., Liu, G., Chu, J. et al. A cell-permeable peptide-based PROTAC against the oncoprotein CREPT proficiently inhibits pancreatic cancer. Theranostics 10, 3708\u20133721 (2020).","journal-title":"Theranostics"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01269-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01269-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01269-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T01:03:54Z","timestamp":1643850234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01269-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,4,12]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01269-1","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"15 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. Archived human specimens were collected under the Ethical Committee of Tsinghua University (IRB-00008273). Written informed consent was obtained from all patients before study entry. Animal experiments were approved by the Institutional Animal Care and Use Committee in Tsinghua University (18-CZJ2).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Raw data and materials generated during the present study are available from the corresponding author upon reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work was supported by grants from the Chinese National Major Scientific Research Programme (2016YFA0500301) and the National Natural Science Foundation of China (81830092, 81572728, 81572729, 81872249 and 81224487).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}